Growth Metrics

CNBX Pharmaceuticals (CNBX) Current Deferred Revenue (2016)

CNBX Pharmaceuticals (CNBX) has disclosed Current Deferred Revenue for 1 consecutive years, with $50000.0 as the latest value for Q2 2016.